22nd Feb 2016 09:36
LONDON (Alliance News) - The following shares received analyst recommendations Monday morning and Friday:
----------
FTSE 100
----------
JEFFERIES RAISES HARGREAVES LANSDOWN PRICE TARGET TO 1203 (1073) PENCE - 'HOLD'
----------
JEFFERIES RAISES ANGLO AMERICAN TARGET TO 275 (215) PENCE - 'UNDERPERFORM'
----------
Investec Puts HSBC Price Target Under Review, Reiterates Buy
----------
JEFFERIES CUTS GLAXOSMITHKLINE PRICE TARGET TO 1300 (1375) PENCE - 'HOLD'
----------
JEFFERIES CUTS ASTRAZENECA PRICE TARGET TO 4900 (5300) PENCE - 'BUY'
----------
JPMORGAN RAISES RECKITT BENCKISER PRICE TARGET TO 7000 (6700) PENCE - 'OVERWEIGHT'
----------
GOLDMAN RAISES RECKITT BENCKISER PRICE TARGET TO 6530 (6365) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES BRITISH AMERICAN TOBACCO PRICE TARGET TO 3460 (3350) PENCE - 'SELL'
----------
EXANE BNP CUTS RIO TINTO PRICE TARGET TO 2000 (2100) PENCE - 'NEUTRAL'
----------
EXANE BNP RAISES BAE SYSTEMS PRICE TARGET TO 548 (537) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES ANGLO AMERICAN PRICE TARGET TO 430 (320) PENCE - 'NEUTRAL'
----------
SOCGEN CUTS BAE SYSTEMS PRICE TARGET TO 560 (565) PENCE - 'BUY'
----------
FTSE 250
----------
JPMORGAN RAISES ESSENTRA TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 926 (955) PENCE
----------
GOLDMAN RAISES TATE & LYLE PRICE TARGET TO 625 (615) PENCE - 'NEUTRAL'
----------
JEFFERIES CUTS TATE & LYLE PRICE TARGET TO 640 (680) PENCE - 'BUY'
----------
CHARLES STANLEY INITIATES HENDERSON GROUP WITH 'BUY' - TARGET 255 PENCE
----------
Investec Initiates BBA Aviation At Buy, Price Target At 225p
----------
MAIN MARKET AND AIM
----------
TRADERS: INVESTEC INITIATES GVC HOLDING WITH 'BUY' - TARGET 545 PENCE
BARCLAYS RAISES AMERISUR RESOURCES TARGET TO 32 (30) PENCE - 'EQUAL WEIGHT'
----------
By Arvind Bhunjun; [email protected]; @ArvindBhunjun
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
AstrazenecaAnglo AmericanRio TintoHSBC HoldingsGVC.LTate & LyleHargreaves LansdownRB..LBBABritish American TobaccoBAE SystemsAMER.LGlaxosmithklineEssentraHGG.L